公众号 / 文章心脑血管急症重症综合管理与镇静镇痛

后可逆性脑病综合征——COVID-19时代不应忽视的病理状态

Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19.
PubMed 文献 · Am J Emerg Med · 2022-03-13
一句话结论COVID-19(Delta变异株)患者出现癫痫、皮质盲、失语时应警惕PRES,急诊快速诊断并早期治疗48小时内症状完全缓解。

本文报告一例38岁既往接触SARS-CoV-2的男性,因全面性强直-阵挛发作、呼吸困难、皮质盲和失语就诊急诊科,此前10天有发热、咳嗽和气促,无相关病史,正按全科医生处方使用抗生素和皮质类固醇。实验室检查和胸部CT符合重症SARS-CoV-2肺炎,脑MRI显示双侧T2加权/FLAIR高信号提示PRES,诊断为COVID-19合并PRES,接受适当治疗后症状48小时内缓解。作者认为这是首例Delta变异株SARS-CoV-2患者中描述的PRES病例,急诊快速诊断和早期启动适当治疗使患者完全康复,对COVID-19伴神经系统症状患者立即进行全面检查对最佳结局至关重要。

要点

  • COVID-19患者出现全面性强直-阵挛发作、皮质盲、失语等神经系统症状时,急诊应警惕PRES并及时行脑MRI检查。
  • 本例脑MRI显示双侧T2加权/FLAIR高信号,支持PRES诊断;胸部CT和实验室检查符合重症SARS-CoV-2肺炎。
  • 诊断为COVID-19合并PRES后接受适当治疗,症状在48小时内缓解。
  • 作者认为,对COVID-19伴神经系统症状患者立即进行全面检查对最佳结局至关重要。
  • 作者称这是首例Delta变异株SARS-CoV-2患者中描述的PRES病例。

适用人群与场景

  • 既往接触过SARS-CoV-2、因全面性强直-阵挛发作、呼吸困难、皮质盲和失语就诊急诊科的38岁患者。
  • 本例患者无相关病史,此前10天有发热、咳嗽和气促,正按全科医生处方使用抗生素和皮质类固醇。

处置流程与药物剂量

  • 对COVID-19伴神经系统症状患者立即进行全面检查(作者认为对最佳结局至关重要)。
  • 本例诊断为COVID-19合并PRES后接受适当治疗,症状在48小时内缓解。

红旗征与不能漏的情况

  • COVID-19患者出现全面性强直-阵挛发作、皮质盲、失语等神经系统症状,需警惕PRES。

研究设计与关键结果

  • 病例报告:38岁男性,既往接触SARS-CoV-2,因全面性强直-阵挛发作、呼吸困难、皮质盲和失语就诊急诊科,此前10天有发热、咳嗽和气促,无相关病史,正使用抗生素和皮质类固醇。
  • 实验室检查和胸部CT符合重症SARS-CoV-2肺炎;脑MRI显示双侧T2加权/FLAIR高信号提示PRES;诊断为COVID-19合并PRES。
  • 接受适当治疗后症状在48小时内缓解。
  • 作者称这是首例Delta变异株SARS-CoV-2患者中描述的PRES病例。

证据类型、等级与局限

  • 证据类型:病例报告。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对COVID-19伴神经系统症状患者立即进行全面检查对最佳结局至关重要;本例急诊快速诊断和早期启动适当治疗使患者完全康复。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) that causes Coronavirus Disease 2019 (COVID-19) may determine a series of neurological complications directly, by invasion of the nervous system or indirectly, secondary to systemic organ failure. Posterior reversible encephalopathy syndrome (PRES) represents a clinical and radiological neurological entity involving predominantly the occipital lobes. PRES was observed in patients receiving cytotoxic drugs, patients suffering from infectious diseases and sepsis, hypertensive emergencies and eclampsia, renal or autoimmune diseases. As more infectious SARS-COV-2 variants are now dominant in most of the Europe, an increasing number of patients is presenting to the Emergency Department.

MATERIALS AND METHODS: Case report of a 38-year-old patient, with previous exposure to SARS-COV-2 presented to the Emergency Department (ED) with generalized tonic-clonic seizures, dyspnea, cortical blindness and aphasia. The patient had been exhibiting fever, cough and shortness of breath in the previous 10 days. He had no relevant medical history and was receiving antibiotics and corticosteroids as prescribed by his general practitioner.

RESULTS: Laboratory findings together with the thoracic computed tomography scan were consistent with the diagnosis of severe SARS-COV-2 pneumonia. The cerebral MRI scans showed bilateral T2-weighted/FLAIR hyperintensities that were suggestive for PRES. The patient was diagnosed with COVID-19 complicated with PRES. He received adequate treatment and the symptoms resolved in 48 h.

CONCLUSIONS: This is a rare and interesting case of a patient with PRES and COVID-19 as underlying pathology, in whom rapid diagnosis in the ED and early initiation of appropriate treatment led to full recovery. Immediate extensive work-up in patients with COVID-19 and neurological symptoms proves to be paramount for best outcome. To our knowledge this is the first case of PRES described in a patient with Delta variant of SARS-COV-2.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ioan P, Ribigan AC, Rusu O, et al. Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19. Am J Emerg Med. 2022. PMID: 35346531. doi:10.1016/j.ajem.2022.03.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。